WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark Agmaset was filed as Word mark on 09/12/2019 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1535483 |
| Register number | 3997624 |
| Countries | 
|
| Base trademark |
No. 3997624,
July 19, 2011
|
| Application date | September 12, 2019 |
| Expiration date | September 12, 2029 |
Trademark owner
531 Silent Siesta Dr.
Henderson NV 89015
US
Henderson NV 89015
US
531 SILENT SIESTA DR.
HENDERSON NV 89015
US
HENDERSON NV 89015
US
goods and services
05
Animal feed additive for use as a nutritional supplement for
medical purposes; animal feed supplements; anti-diabetic
pharmaceuticals; anti-diabetic preparations; antidiabetic
preparations; dietary and nutritional supplements; dietary
and nutritional supplements for endurance sports; dietary
and nutritionally fortified food products adapted for
medical use; dietary beverage supplements for human
consumption in liquid and dry mix form for therapeutic
purposes; dietary drink mix for use as a meal replacement
(terms too vague in the opinion of the International Bureau
– Rule 13 (2) (b) of the Regulations); dietary food
supplements; dietary pet supplements in the form of pet
treats; dietary supplement beverage for aiding nerve health;
dietary supplemental drinks; dietary supplemental drinks in
the nature of vitamin and mineral beverages; dietary
supplements; dietary supplements for animals; dietary
supplements for human consumption; dietary supplements for
pets; dietary supplements for pets in the nature of a
powdered drink mix; dietary supplements for aiding nerve
health; feed supplements for pets, livestock; food
supplements; food supplements for aiding nerve health; foods
for individuals with special dietary requirements
necessitated by medical treatments; health food supplements;
homeopathic supplements; liquid nutritional supplement; meal
replacement and dietary supplement drink mixes; medicated
supplements for foodstuffs for animals; natural supplements
for treating depression and anxiety; non-medicated additives
for animal feed for use as nutritional supplements;
nutraceuticals for use as a dietary supplement;
nutraceuticals for use as a dietary supplement for aiding
nerve health; nutritional additives for medical purposes for
use in foods and dietary supplements for human consumption;
nutritional additives for medical purposes used in foods and
dietary supplements for human consumption; nutritional and
dietary supplements formed and packaged as bars; nutritional
supplements; nutritional supplements for aiding nerve
health; nutritional supplements in capsule form for dogs;
nutritional supplements in lotion form sold as a component
of nutritional skin care products; ophthalmic preparations;
ophthalmologic preparations; ophthalmological preparations;
pharmaceutical preparations acting on the central nervous
system; pharmaceutical preparations and substances for the
treatment of damaged skin and tissue; pharmaceutical
preparations and substances for the treatment of infectious
diseases, blood disorders, pain, inflammation, sepsis,
alopecia, obesity and cognitive disorders; pharmaceutical
preparations and substances for the treatment of psychiatric
diseases and disorders; pharmaceutical preparations for the
prevention and treatment of disorders of the nervous system,
the immune system, the cardio-vascular system, the metabolic
system, the respiratory system, the musculo-skeletal system,
the genitourinary system; for the treatment of inflammatory
disorders (terms linguistically incorrect in the opinion of
the International Bureau – Rule 13 (2) (b) of the
Regulations); for use in dermatology, oncology, hematology
and in tissue and organ transplantation, in ophthalmology
and for gastroenterological disorders (terms linguistically
incorrect in the opinion of the International Bureau – Rule
13 (2) (b) of the Regulations); pharmaceutical preparations
for the prevention and treatment of ocular disorders or
diseases, bacteria-based diseases or disorders, autoimmune
diseases or disorders, kidney diseases or disorders, and
diabetes; pharmaceutical preparations for the prevention of
nervous system damage; pharmaceutical preparations for the
treatment and prevention of nervous system damage;
pharmaceutical preparations for the treatment of eye
diseases and conditions; pharmaceutical preparations for the
treatment of kidney diseases; pharmaceutical preparations
for the treatment of nervous system damage; pharmaceutical
preparations for treating diabetes; pharmaceutical
preparations for treating skin disorders; pharmaceutical
preparations for use in chemotherapy; pharmaceutical
preparations for nervous system damage; pharmaceutical
preparations, namely, a topical preparation for the
treatment of ocular disorders prescribed by
ophthalmologists, eye surgeons, and optometrists;
pharmaceutical preparations, namely, antidepressants;
pharmaceutical products for ophthalmological use;
pharmaceutical products for the prevention and treatment of
cancer; powdered nutritional supplement drink mix;
preparation for the relief of pain; therapeutic
pharmaceutical for the treatment of nervous system damage
(terms linguistically incorrect in the opinion of the
International Bureau – Rule 13 (2) (b) of the Regulations);
veterinary preparations for nervous system damage;
veterinary preparations, namely, pain relief medication;
vitamins and dietary food supplements for animals
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| March 22, 2023 | 2023/12 Gaz | PH | RAW: Total Invalidation |
| December 5, 2020 | 2020/50 Gaz | PH | Rejection |
| September 12, 2019 | 2020/22 Gaz | US | Registration |
ID: 141535483